02 Oct 2025 How to value flexible operation in Energy-Intensive Industries: Technical and economic assessment in the EU Energy
30 Sept 2025 Major Banks Granted Summary Judgment in LIBOR-Based Antitrust Litigation Case Financial Institutions & Products
Insights Healthcare & Life Sciences Search Search insight Filters Type Type… News Publications Services… Antitrust & Competition Antitrust & Competition: Mergers Antitrust & Competition: Conduct Antitrust & Competition: Damages Mergers & Acquisition Litigation Industries… Healthcare & Life Sciences Healthcare & Life Sciences Clear all Showing 1–4 of 4 results News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry Article • 05 Dec 2011 The Economic Benefits of Pharmacy Benefit Managers - J. Orszag & K. Green Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients
News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon
Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry
Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients